Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter‐4 and increasing glucokinase
Open Access
- 7 July 2010
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 161 (5), 1137-1149
- https://doi.org/10.1111/j.1476-5381.2010.00956.x
Abstract
BACKGROUND AND PURPOSE Hyperleptinemia is commonly found in obese patients, associated with non-alcoholic steatohepatitis and hepatic fibrosis. Hepatic stellate cells (HSCs) are the most relevant effectors during hepatic fibrogenesis. We recently reported that leptin stimulated HSC activation, which was eliminated by curcumin, a phytochemical from turmeric. This study was designed to explore the underlying mechanisms, focusing on their effects on intracellular glucose in HSCs. We hypothesized that leptin stimulated HSC activation by elevating the level of intracellular glucose, which was eliminated by curcumin by inhibiting the membrane translocation of glucose transporter-4 (GLUT4) and inducing the conversion of glucose to glucose-6-phosphate (G-6-P). EXPERIMENTAL APPROACH Levels of intracellular glucose were measured in rat HSCs and immortalized human hepatocytes. Contents of GLUT4 in cell fractions were analysed by Western blotting analyses. Activation of signalling pathways was assessed by comparing phosphorylation levels of protein kinases. KEY RESULTS Leptin elevated the level of intracellular glucose in cultured HSCs, which was diminished by curcumin. Curcumin suppressed the leptin-induced membrane translocation of GLUT4 by interrupting the insulin receptor substrates/phosphatidyl inositol 3-kinase/AKT signalling pathway. Furthermore, curcumin stimulated glucokinase activity, increasing conversion of glucose to G-6-P. CONCLUSIONS AND IMPLICATIONS Curcumin prevented leptin from elevating levels of intracellular glucose in activated HSCs in vitro by inhibiting the membrane translocation of GLUT4 and stimulating glucose conversion, leading to the inhibition of HSC activation. Our results provide novel insights into mechanisms of curcumin in inhibiting leptin-induced HSC activation.Keywords
This publication has 62 references indexed in Scilit:
- Curcumin suppresses expression of low‐density lipoprotein (LDL) receptor, leading to the inhibition of LDL‐induced activation of hepatic stellate cellsBritish Journal of Pharmacology, 2009
- Curcumin Eliminates Leptin’s Effects on Hepatic Stellate Cell Activation via Interrupting Leptin SignalingEndocrinology, 2009
- Dorsal Hindbrain 5′-Adenosine Monophosphate-Activated Protein Kinase as an Intracellular Mediator of Energy BalanceEndocrinology, 2008
- Liver diseases and metabolic syndromeThe Esophagus, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Curcumin: potential for hepatic fibrosis therapy?British Journal of Pharmacology, 2008
- Curcumin Inhibits Neurotensin-Mediated Interleukin-8 Production and Migration of HCT116 Human Colon Cancer CellsClinical Cancer Research, 2006
- Papel del GLUT2 en la utilización de los azúcares de la dieta (minirrevisión)Journal of Physiology and Biochemistry, 2005
- Leptin: a review of its peripheral actions and interactionsInternational Journal of Obesity, 2002
- Abnormal splicing of the leptin receptor in diabetic miceNature, 1996